Maiva Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
as on 29-10-2024
- Paid Up Capital ₹ 1.63 M
as on 29-10-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 124.00 Cr
as on 29-10-2024
About Maiva Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.10 M and a paid-up capital of Rs 1.63 M.
The company currently has active open charges totaling ₹124.00 Cr.
Buggana Hariharnath, Arumugam Krishna, Nirav Mehta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110TN2022PTC154153
- Company No.
154153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Krishnagiri, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maiva Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirav Mehta  | Director | 16-May-2024 | Current |
Buggana Hariharnath  | Director | 26-Sep-2024 | Current |
| Arumugam Krishna | Director | 21-Jul-2022 | Current |
| Janardhan | Director | 17-Aug-2024 | Current |
| Vaibhav Bagri | Director | 17-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Maiva Lifesciences.
Maiva Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maiva Lifesciences?
In 2023, Maiva Lifesciences had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Morgan Stanley Investment Management Private LimitedActive 31 years 2 monthsNirav Mehta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Dec 2023 | ₹124.00 Cr | Open |
How Many Employees Work at Maiva Lifesciences?
Maiva Lifesciences has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maiva Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maiva Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
